Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GIP: Synergizes with GLP-1 to further reduce appetite, improve fat metabolism, and mitigate side effects
Key Benefits (from Clinical Trials) Phase 2 clinical trials have shown promising, dose-dependent results when used alongside diet and exercise: Significant Weight Loss: Participants on the highest dose (12 mg) lost up to 24.2% of their body weight over 48 weeks, a result that surpasses current approved medications like Mounjaro and Wegovy in trial comparisons
Naast het stimuleren van de aanmaak van insuline, communiceert GLP-1 een verzadigd gevoel naar de hersenen, zorgt het ervoor dat voedsel langer in de maag blijft en je daardoor langer vol zit, werkt het ontstekingsremmend en heeft het een beschermend effect op de hart-, vaat-, en hersengezondheid (1)
Pancreatitis: There have been reports of acute pancreatitis (inflammation of the pancreas) associated with GLP-1 receptor agonists
If nausea or vomiting becomes severe or persistent, speak with your healthcare provider
However, these drugs were all intentionally made to treat type 2 diabetes
US$ 23.32
US$ 27.01
US$ 20.74
US$ 20.66
US$ 21.76
US$ 26.33
US$ 20.72
US$ 23.22
